The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-benzyl-2-(1-(naphthalen-1-ylsulfonyl)-1H-indol-4-yloxy)ethanamine ID: ALA4872486
PubChem CID: 164623922
Max Phase: Preclinical
Molecular Formula: C27H24N2O3S
Molecular Weight: 456.57
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=S(=O)(c1cccc2ccccc12)n1ccc2c(OCCNCc3ccccc3)cccc21
Standard InChI: InChI=1S/C27H24N2O3S/c30-33(31,27-15-6-11-22-10-4-5-12-23(22)27)29-18-16-24-25(29)13-7-14-26(24)32-19-17-28-20-21-8-2-1-3-9-21/h1-16,18,28H,17,19-20H2
Standard InChI Key: KDUPOZXXJNAMJQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 37 0 0 0 0 0 0 0 0999 V2000
3.3688 -17.5436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3676 -18.3718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7976 -17.5400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0814 -17.1304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5113 -17.1243 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.2280 -17.5346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9417 -17.1190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6585 -17.5292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3722 -17.1136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0889 -17.5238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8010 -18.3734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0862 -18.7817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2534 -19.5876 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0718 -19.6776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4101 -18.9271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4130 -20.6094 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6998 -20.1964 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.6988 -21.0206 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8940 -20.0265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6427 -19.2400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8361 -19.0661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2811 -19.6790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0892 -18.3498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8051 -18.7599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5198 -18.3443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5140 -17.5141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7975 -17.1076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3444 -20.6383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5403 -20.4711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9983 -21.0831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2535 -21.8625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0614 -22.0265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6027 -21.4131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 12 1 0
11 3 1 0
3 4 2 0
4 1 1 0
3 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 15 2 0
15 11 1 0
17 16 2 0
18 17 2 0
13 17 1 0
17 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 29 1 0
28 19 1 0
10 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 10 1 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 33 1 0
33 28 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 456.57Molecular Weight (Monoisotopic): 456.1508AlogP: 5.20#Rotatable Bonds: 8Polar Surface Area: 60.33Molecular Species: BASEHBA: 5HBD: 1#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 8.92CX LogP: 5.19CX LogD: 3.67Aromatic Rings: 5Heavy Atoms: 33QED Weighted: 0.33Np Likeness Score: -0.97
References 1. Wichur T, Godyń J, Góral I, Latacz G, Bucki A, Siwek A, Głuch-Lutwin M, Mordyl B, Śniecikowska J, Walczak M, Knez D, Jukič M, Sałat K, Gobec S, Kołaczkowski M, Malawska B, Brazzolotto X, Więckowska A.. (2021) Development and crystallography-aided SAR studies of multifunctional BuChE inhibitors and 5-HT6 R antagonists with β-amyloid anti-aggregation properties., 225 [PMID:34530376 ] [10.1016/j.ejmech.2021.113792 ]